| Innovation Dynamics provides a range of business advisory services to life science companies, investors, research centres and to Government in Australia and overseas and is a major consulting firm in the biological sciences regionally. The founders, Dr Kelvin Hopper (Executive Chairman) and Dr Lyndal Thorburn (CEO) and senior consultants in the company have extensive experience on commercialisation in technology-based industries. The Company operates from offices in Sydney, Melbourne and Canberra.
The Company has completed numerous projects over the last two years involving strategy development, market research and business structuring for the commercialisation of biological products including drugs, diagnostics, medical devices, software, agricultural products and electronics. Innovations Dynamics holds an investment advisors licence from ASIC and have prepared many expert reports and valuations of technology for capital raising and conducted technology/commercial due diligence.
| Go to website>>
|
| | Dr Thorburn
| Dr Thorburn is Managing Director & principal of Innovation Dynamics Pty Ltd and founder of Advance® Consulting & Evaluation. She has 15 years experience in financial management, strategic planning, technology transfer, innovation & research commercialisation in the private sector, CSIRO & government. Formal qualifications in science, legal studies & economic geography have been supplemented by ongoing training in intellectual property protection and management; marketing and media relations; and project and research management. She continues to be a Research Associate at Macquarie University and in 2004 was appointed Adjunct Professor in commercialisation at the University of Canberra.
Dr Thorburn is a past Director of The Australian Biotechnology Association (now AusBiotech Ltd). In 2001 she was appointed to the International Advisory Board of the University of Ulster Research Park in Northern Ireland. In 2002 she was an ACT finalist in the Business Owners' category of the Telstra Business Women's Award. In 2004 her first company, Advance Consulting and Evaluation, was an ACT finalist in the Telstra Small Business Awards (Micro-business category). Dr Thorburn was also awarded the Telstra ACT Businesswoman of the Year Award for 2004.
|
| | Dr Hopper
| Dr Hopper is Executive Chairman of Innovation Dynamics and is Managing Director and founder of Aoris Nova Pty Ltd. He has broad experience spanning biomedical research, commercial R&D, marketing and operations in biotechnology. He is director of several companies including a founding shareholder in BioFusion Capital, a specialist biotechnology fund with links throughout Asia. He gained operational and strategic management experience from senior positions with the biotechnology company, Monoclonal Australia Limited, and ICI Australia. Earlier, Dr Hopper carried out original research in immunology, cancer, infectious diseases and parasitology in a number of institutions - the Max Planck Institute fur Biochemie (Munich), the Walter & Eliza Hall Institute (Melbourne) and the Kolling Institute of Medical Research at Royal North Shore Hospital (Sydney).
Dr Hopper is the licensee on the AFS licence held by Innovation Dynamics and has written many expert reports, strategies, opinions and valuations. He is a member of the Platform Management Committee for the Integrated Neuroscience Facility and regularly lectures on business strategy to universities. He started the influential BioBusiness Forums in Sydney and co-authors the annual BioIndustry Review (with Dr Lyndal Thorburn), a critical analysis of trends in the biotechnology sector in Australia and New Zealand. He has formal qualifications in chemistry, finance and physical biochemistry
BSc (Chemistry, Melbourne); Dipl. Textile Chem. (Deakin); Cert. Financial Management (UTS); PhD (Physical. Biochem., ANU)
|
|
|
|
